Chantal Chavoix

Chantal Chavoix

Auto-generated profile, based on publicly available information

Chantal Chavoix

Normandie Univ., UNICAEN, INSERM U1075, COMETE , Caen , France

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
CCChantal Chavoix
Chantal Chavoix
Ricardo InsaustiRicardo Insausti
Ricardo Insausti

30 January 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
GLGilles Loggia
Gilles Loggia
EAElpidio Attoh-Mensah
Elpidio Attoh-Mensah
KPKristell Pothier
Kristell Pothier
RMRémy Morello
Rémy Morello
PLPascale Lescure
Pascale Lescure
CCChantal Chavoix
Chantal Chavoix
Objectives: With their broad spectrum of action, psychotropic drugs are among the most common medications prescribed to the elderly. Consequently, the number of older adults taking multiple psychotropic drugs has more than doubled over the last decade. To improve knowledge about the deleterious effects of psychotropic polypharmacy, we investigated whether there is a threshold number of psychotropic molecules that could lead to impairment of global cognition, executive function, or mobility. Furthermore, relationships between the number of psychotropic molecules and cognitive and mobility impairment were examined. Design: Cross-sectional study Setting: University Hospital of Caen (France) and advertisements in medical offices Participants: Community-dwelling older adults 55 years and older (n = 177; 69.8 ± 9.3 years; 81% women) Measurements: Number of psychotropic molecules taken daily, global cognition assessed with the Mini Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA), processing speed with the Trail Making Test (TMT) A, executive function with the TMT B and TMT B-A, and mobility with the Time Up and Go (TUG). The threshold numbers of psychotropic molecules were determined by ROC curves analysis. Based on these threshold values, multinomial logistic regression adjusting for covariates was then performed. Results: Logistic regressions showed that the threshold of two daily psychotropic molecules, identified by the ROC curves analysis, increases the risk of impaired executive function (p = .05 and.005 for the TMT B and TMT B-A, respectively), global cognition (p = .006 and.001 for the MMSE and MoCA, respectively), and mobility (p = .005 for the TUG), independent of confounding factors, including comorbidities. Furthermore, psychotropic polypharmacy would affect mobility through executive functions. Conclusion: Impairment of global cognition, executive function, and mobility when as few as two psychotropic molecules are consumed in relatively healthy young older adults should alert physicians when prescribing combinations of psychotropic medications.

13 January 2020 in Drugs & Aging
Verified
Journal Article
Closed access
PDF file
EAElpidio Attoh-Mensah
Elpidio Attoh-Mensah
GLGilles Loggia
Gilles Loggia
PSPascale Schumann-Bard
Pascale Schumann-Bard
RMRémy Morello
Rémy Morello
PDPablo Descatoire
Pablo Descatoire
CCChantal Chavoix
Chantal Chavoix

1 March 2021 in Annals of Physical and Rehabilitation Medicine
Verified
Journal Article
Closed access
APAlice Pellichero
Alice Pellichero
SLSylviane Lafont
Sylviane Lafont
LPLaurence Paire-Ficout
Laurence Paire-Ficout
CFColette Fabrigoule
Colette Fabrigoule
CCChantal Chavoix
Chantal Chavoix

14 December 2020 in The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences
Verified
Journal Article
Closed access
LPLaurence Pair-Ficout
Laurence Pair-Ficout
SLSylviane Lafont
Sylviane Lafont
MHMarion Hay
Marion Hay
ACAmandine Coquillat
Amandine Coquillat
CFColette Fabrigoule
Colette Fabrigoule
CCChantal Chavoix
Chantal Chavoix
Objectives: Many older drivers incorrectly estimate their driving ability. The present study aimed to determine whether, and if so, to what extent unawareness of cognitive abilities affects self-awareness of driving ability. Method: Two successive studies were conducted in older drivers. A cohort study investigated cognitive self-awareness and an experimental study examined driving self-awareness. In each one, self-awareness was assessed by cross-analyzing objective (respectively Trail-Making Tests A and B and the Digit Symbol Substitution Test and driving performance of on-road assessment) and subjective data (responses about everyday cognitive skills and driving ability). Older drivers were then classified as being over-, correct, or underestimators. The 3 cognitive and driving self-awareness profiles were then cross-analyzed. Results: In the cohort study, 1,190 drivers aged 70 years or older were included. The results showed that 42.7% of older drivers overestimated their cognitive ability, 42.2% estimated it correctly, and 15.1% underestimated it. The experimental study included 145 participants from the cohort. The results showed that 34% of participants overestimated, 45% correctly estimated, and 21% underestimated their driving ability. There was a significant relationship between cognitive and driving self-awareness profiles (p = .02). This overlap was more marked in overestimators. Discussion: Significant overlap between cognitive and driving self-awareness provides useful and new knowledge about driving in the aging population. Misestimation of cognitive ability could hamper self-awareness of driving ability, and consequently self-regulation of driving. It is now crucial to develop measures that promote self-awareness of ability.

30 August 2007 in Journal of Neuroimaging
Verified
Journal Article
Closed access
PDF file
RMRose‐Marie Marié
Rose‐Marie Marié
CLCatherine Lozza
Catherine Lozza
CCChantal Chavoix
Chantal Chavoix
GDGilles DEFER
Gilles DEFER
Claude BaronClaude Baron
Claude Baron